An efficient approach to isolation and characterization of pre- and postnatal umbilical cord lining stem cells for clinical applications

Cell Transplantation

Volumn 19, Issue 11, 2010, Pages 1439-1449

  Gonzalez, Rafael ^a   Griparic, L ^a   Umana, M ^a   Burgee, K ^a   Vargas, V ^a   Nasrallah, R ^a   Silva, F ^a   Patel, A ^b,c  

^a DaVinci Biosciences LLC   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Cell banking; Clinical applications; Differentiation; Mesenchymal stem cells; Multipotent; Umbilical cord lining

Indexed keywords

CELL MARKER; OCTAMER TRANSCRIPTION FACTOR 4; RNA; STAGE SPECIFIC EMBRYO ANTIGEN 4; TRANSCRIPTION FACTOR NANOG;

ADIPOCYTE; ARTICLE; BONE DEVELOPMENT; CARDIOGENIC CELL; CARTILAGE CELL; CELL COUNT; CELL DIFFERENTIATION; CELL EXPANSION; CELL GROWTH; CELL ISOLATION; CELL KINETICS; CELL LINEAGE; CELL STRUCTURE; CONTROLLED STUDY; EMBRYO; FLOW CYTOMETRY; GENOTYPE PHENOTYPE CORRELATION; HEART MUSCLE CELL; HLA MATCHING; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; KARYOTYPING; MESENCHYMAL STEM CELL; NERVE CELL; OSTEOBLAST; PERINATAL PERIOD; PLURIPOTENT STEM CELL; PRENATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; UMBILICAL CORD BLOOD;

CELL DIFFERENTIATION; CELL LINEAGE; CELL SEPARATION; FLOW CYTOMETRY; GENOTYPE; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; OCTAMER TRANSCRIPTION FACTOR-3; PHENOTYPE; STAGE-SPECIFIC EMBRYONIC ANTIGENS; STEM CELLS; UMBILICAL CORD;

EID: 78651518115     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368910X514260     Document Type: Article

References (35)

1. Baksh, D.; Yao, R.; Tuan, R. S. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25:1384-1392; 2007.
2. Balduzzi, A.; Gooley, T.; Anasetti, C.; Sanders, J. E.; Martin, P. J.; Petersdorf, E. W.; Appelbaum, F. R.; Buckner, C. D.; Matthews, D.; Storb, R.; Sullivan, K. M.; Hansen, J. A. Unrelated donor marrow transplantation in children. Blood 86(8):3247-3256; 1995.
3. Barry, F. P.; Murphy, J. M.; English, K.; Mahon, B. P. Immunogenicity of adult mesenchymal stem cells: Lessons from the fetal allograft. Stem Cells Dev. 14:252-265; 2005.
4. Can, A.; Karahuseyingoglu, S. Concise review: Human umbilical cord stroma with regards to the source of fetus-derived stem cells. Stem Cells 25:2886-2895; 2007.
5. Carlin, R.; Davis, D.; Weiss, M.; Schultz, B.; Troyer, D. Expression of early transcription factors Oct-4, Sox-2 and Nanog by porcine umbilical cord (PUC) matrix cells. Reprod. Biol. Endocrinol. 4:8; 2006.
6. Cogle, C. R.; Yachnis, A. T.; Laywell, E. D.; Zander, D. S.; Wingard, D. R.; Steindler, D. A.; Scott, E. W. Bone marrow trans differentiation in brain after transplantation: A retrospective study. Lancet 363:1432-1437; 2004.
7. Cristofalo, V. J.; Allen, R. G.; Pignolo, R. J.; Martin, B. G.; Beck, J. C. Relationship between donor age and the replicative lifespan of human cells in culture: A reevaluation. Proc. Natl. Acad. Sci. USA 95:10614-10619; 1998.
8. De Coppi, P.; Bartsch, G.; Siddiqui, M. M. Isolation of amniotic stem cells with potential for therapy. Nat. Biotech. 25:100-106; 2007.
9. Dominici, M.; Le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D. J.; Horwitz, E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315-317; 2006.
10. Fong, C. Y.; Richards, M.; Manasi, N.; Biswas, A.; Bongso, A. Comparitive growth behavior and characterization of stem cells from human Wharton's jelly. Reprod. Biomed. Online 15(6):708-718; 2007.
11. Gang, E. J.; Bosnakovski, D.; Figueiredo, C. A.; Visser, J. W.; Perlingeiro, R. C. SSEA-4 identifies mesenchymal stem cells from bone marrow. Blood 109(4):1743-1751; 2007.
12. Harris, D. T. Cord blood stem cells: A review of potential neurological applications. Stem Cell Rev. 4:269-274; 2008.
13. Karahuseyinoglu, S.; Cinar, O.; Kilic, E.; Kara, F.; Akay, G. G.; Demiralp, D. O.; Tukun, A.; Uckan, D.; Can, A. Biology of stem cells in human umbilical cord stroma: In situ and in vitro surveys. Stem Cells 25:319-331; 2007.
14. Kita, K.; Gauglitz, G. G.; Phan, T. T.; Herndon, D. N.; Jeschke, M. G. Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev. 19(4):491-502; 2010.
15. Kuo, T. K.; Ho, J. H.; Lee, O. K. Mesenchymal stem cell therapy for nonmusculoskeletal diseases: Emerging applications. Cell Transplant. 18(9):1013-1028; 2009.
16. Kurtzberg, J.; Lyerly, A. D.; Sugarman, J. Untying the Gordian knot: Policies, practices, and ethical issues related to banking of umbilical cord blood. J. Clin. Invest. 115(10):2592-2597; 2005.
17. Le Blanc, K. Immunomodulatory effects of fetal and adult mesenchymal stem cells. Cytotherapy 5(6):484-489; 2003.
18. Le Blanc, K.; Götherström, C.; Ringdén, O.; Hassan, M.; McMahon, R.; Horwitz. E.; Anneren, G.; Axelsson, O.; Nunn, J.; Ewald, U.; Nordén-Lindeberg, S.; Jansson, M.; Dalton, A.; Aström, E.; Westgren, M. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 79:1607-1614; 2005.
19. Mavroudis, D.; Read, E.; Cottler-Fox, M.; Couriel, D.; Molldrem, J.; Carter, C.; Yu, M.; Dunbar, C.; Barrett, J. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 88(8):3223-3229; 1996.
20. Nandoe Tewerie, R. D.; Hurtado, A.; Levi, A. D.; Grotenhuis, J. A.; Oudega, M. Bone marrow stromal cells for repair of the spinal cord: Towards clinical application. Cell Transplant. 15(7):563-577; 2006.
21. Newcomb, J. D.; Sanberg, P. R.; Klasko, S. K.; Willing, A. E. Umbilical cord blood research: Current and future perspectives. Cell Transplant. 16(2):151-158; 2007.
22. Ohnishi, S.; Nagaya, N. Prepare cells to repair the heart: Mesenchymal stem cells for the treatment of heart failure. Am. J. Nephrol. 27(3):301-307; 2007.
23. Parolini, O.; Alviano, F.; Bagnara, G. P.; Bilic, G.; Bühring, H. J.; Evangelista, M.; Hennerbichler, S.; Liu, B.; Magatti, M.; Mao, N.; Miki, T.; Marongiu, F.; Nakajima, H.; Nikaido, T.; Portmann-Lanz, C. B.; Sankar, V.; Soncini, M.; Stadler, G.; Surbek, D.; Takahashi, T. A.; Redl, H.; Sakuragawa, N.; Wolbank, S.; Zeisberger, S.; Zisch, A.; Strom, S. C. Concise review: Isolation and characterization of cells from human term placenta: Outcome of the first international Workshop on Placenta Derived Stem Cells. Stem Cells 26:300-311; 2008.
24. Rocha, V.; Labopin, M.; Sanz, G.; Arcese, W.; Schwerdtfeger, R.; Bosi, A.; Jacobsen, N.; Ruutu, T.; de Lima, M.; Finke, J.; Frassoni, F.; Gluckman, E. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N. Engl. J. Med. 351(22): 2276-2285; 2004.
25. Rocha, V.; Wagner, Jr., J. E.; Sobocinski, K. A.; Klein, J. P.; Zhang, M. J.; Horowitz, M. M.; Gluckman, E. Graft- versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. N. Engl. J. Med. 321(17):1174-1178; 1989.
26. Rogers, I.; Casper, R. F. Umbilical cord blood stem cells. Best Pract. Res. Clin. Obstet. Gynaecol. 18(6):893-908; 2004.
27. Sarugaser, R.; Lickorish, D.; Baksh, D.; Hosseini, M. M.; Davies, J. E. Human umbilical cord perivascular (HUCPV) cells: A source of mesenchymal progenitors. Stem Cells 23:220-229; 2005.
28. Simmons, P.; Torok-Storb, B. Identification of stromal precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 78(1):55-62; 1991.
29. Tang, Y.; Yasuhara, T.; Hara, K.; Matsukawa, N.; Maki, M.; Yu, G.; Xu, L.; Hess, D. C.; Borlongan, C. V. Transplantation of bone marrow derived stem cells: A promising therapy for stroke. Cell Transplant. 16(2):159-169; 2007.
30. Torrente, Y.; Polli, E. Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant. 17(10-11):1103-1113; 2008.
31. Vilquin, J. T.; Rosset, P. Mesenchymal stem cells in bone and cartilage repair: Current status. Regen. Med. 1(4): 589-604; 2006.
32. Weiss, M. L.; Medicetty, S.; Bledsoe, A. R.; Rachakatla, R. S.; Choi, M.; Merchav, S.; Luo, Y.; Rao, M. S.; Velagaleti, G.; Troyer, D. Human umbilical cord matrix stem cells: Preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 24:781-792; 2006.
33. Weiss, M. L.; Troyer, D. L. Stem cells in the umbilical cord. Stem Cell Rev. 2(2):155-162; 2006.
34. Woodbury, D.; Schwarz, E. J.; Prockop, D. J.; Black, I. B. Adult rat and human bone marrow stromal cells differentiate into neurons. J. Neurosci. Res. 61:364-370; 2000.
35. Zurita, M.; Vaquero, J. Functional recovery in chronic paraplegia after bone marrow stromal cells transplantation. Neuroreport 15(7):1105-1108; 2004.